ArticleHealthcare (Basel, Switzerland)2021

May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia.

Javier Molina-Cerrillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.